SPY765.44QQQ737.07+0.07%BTC/USD84,268.40+0.97%DIA513.82−0.04%GLD379.46+0.41%TLT78.63+0.01%
Benzinga

Braveheart Bio Inc (BRVE) Stock Price, Quote, News & History

BRVENASDAQ
Trade with Public
Trade with Public
$21.07
0.452.18%
At close: Sep 25, 5:00 PM EST
$21.07
0.452.18%
Pre-Market: 4:01 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Braveheart Bio (BRVE) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$21.07
Volume / Avg.
0 / 543.38K
Day Range
- - -
52 Wk Range
20.01 - 32.00
Market Cap
$1.90B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
-
Days to Cover
7.49

Recent Braveheart Bio, Inc. News

This Airbnb Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst
Avi Kapoor

This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI
Avi Kapoor

PRO
Braveheart Bio Q2 EPS $(2.51)

Braveheart Bio (NASDAQ:BRVE) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $0.74 by 439.19 percent. This is a 1692.86 percent decrease over losses of $(0.14) per share
Benzinga Newsdesk

PRO
Goldman Sachs Initiates Coverage On Braveheart Bio with Buy Rating, Announces Price Target of $48

Goldman Sachs analyst Salveen Richter initiates coverage on Braveheart Bio (NASDAQ:BRVE) with a Buy rating and announces Price Target of $48.
Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Braveheart Bio with Buy Rating

TD Cowen analyst Tyler Van Buren initiates coverage on Braveheart Bio (NASDAQ:BRVE) with a Buy rating.
Benzinga Newsdesk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-24.15M
Investing Cash Flow (TTM)
-36.60M
Financing Cash Flow (TTM)
183.58M
Free Cash Flow (TTM)
-60.75M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
122.83M

Analyst Trends and Forecast

5
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.77B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-7.58%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$1.07

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$122.83M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$21.07
Volume / Avg.
0 / 543.38K
Day Range
- - -
52 Wk Range
20.01 - 32.00
Market Cap
$1.90B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
-
Days to Cover
7.49

About

Sector
Health Care
Industry
Pharmaceuticals
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Braveheart Bio (BRVE) stock?

A

You can purchase shares of Braveheart Bio (NASDAQ:BRVE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Braveheart Bio (BRVE) competitors?

Q

What is the forecast, or price target, for Braveheart Bio (BRVE) stock?

A

Braveheart Bio has a consensus price target of $45.25.

Q

What is the current price for Braveheart Bio (BRVE)?

A

The stock price for Braveheart Bio (NASDAQ: BRVE) is $21.07 last updated September 28, 2026 at 4:41 PM EDT.

Q

Does Braveheart Bio (BRVE) pay a dividend?

A

There are no upcoming dividends for Braveheart Bio.

Q

When is Braveheart Bio (NASDAQ:BRVE) reporting earnings?

A

Braveheart Bio does not have any upcoming earnings scheduled.

Q

Is Braveheart Bio (BRVE) going to split?

A

There is no upcoming split for Braveheart Bio.

Q

What sector and industry does Braveheart Bio (BRVE) operate in?

A

Braveheart Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved